- Home
- ORGO vs GILT Comparison
ORGO vs GILT Comparison
Compare ORGO & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- GILT
- Stock Information
- Founded
- ORGO 1985
- GILT 1987
- Country
- ORGO United States
- GILT Israel
- Employees
- ORGO N/A
- GILT N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- GILT Radio And Television Broadcasting And Communications Equipment
- Sector
- ORGO Health Care
- GILT Technology
- Exchange
- ORGO Nasdaq
- GILT Nasdaq
- Market Cap
- ORGO 465.6M
- GILT 429.7M
- IPO Year
- ORGO N/A
- GILT 1993
- Fundamental
- Price
- ORGO $4.51
- GILT $7.35
- Analyst Decision
- ORGO Buy
- GILT Strong Buy
- Analyst Count
- ORGO 2
- GILT 2
- Target Price
- ORGO $6.50
- GILT $8.50
- AVG Volume (30 Days)
- ORGO 895.4K
- GILT 497.3K
- Earning Date
- ORGO 08-07-2025
- GILT 08-06-2025
- Dividend Yield
- ORGO N/A
- GILT N/A
- EPS Growth
- ORGO N/A
- GILT N/A
- EPS
- ORGO N/A
- GILT 0.24
- Revenue
- ORGO $458,760,000.00
- GILT $321,407,000.00
- Revenue This Year
- ORGO $3.50
- GILT $42.88
- Revenue Next Year
- ORGO $8.59
- GILT $13.26
- P/E Ratio
- ORGO N/A
- GILT $30.63
- Revenue Growth
- ORGO 5.35
- GILT 13.49
- 52 Week Low
- ORGO $2.28
- GILT $4.04
- 52 Week High
- ORGO $6.71
- GILT $8.55
- Technical
- Relative Strength Index (RSI)
- ORGO 53.20
- GILT 48.19
- Support Level
- ORGO $4.67
- GILT $7.28
- Resistance Level
- ORGO $5.15
- GILT $7.91
- Average True Range (ATR)
- ORGO 0.28
- GILT 0.27
- MACD
- ORGO -0.04
- GILT -0.10
- Stochastic Oscillator
- ORGO 53.70
- GILT 8.40
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.